ETF recommends updating COVID-19 vaccines to target new JN.1 variant
ETF recommends updating COVID-19 vaccines to target new JN.1 variant
ETF recommends updating COVID-19 vaccines to target new JN.1 variant
Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 6, Status: Authorised
Withdrawn application: Orencia, 19/02/2024
IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
Minutes of the CAT meeting 13-15 March 2024
Creon (pancrelipase/pancreas powder) supply shortage
Agenda - 12th meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines
12th meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 June 2024, 13:00 (CEST) to 19 June 2024, 18:00 (CEST)
Final Minutes – HMA-EMA joint Big Data Steering Group teleconference - 22 March 2024
EMA closed 1 May